News & Events
decoration

Call for Grants Round 2 2019

Maddie Riewoldt’s Vision is delighted to release our Call for Grants Round 2, 2019. Opening 1st November, two categories are available in Round 2:
  1. Grants-In-Aid, to support research projects into the causes and treatment of Bone Marrow Failure (BMF) – $50,000 AUD per annum for up to two years
  2. Programs, high clinical impact, multidisciplinary investigators/multiple site research collaboration of international standard – $1 million AUD to be awarded over a minimum three and maximum of five year period.

We seek expressions of interest from appropriately qualified scientific or medical researchers and research that is specifically directed towards finding a cure for both congenital and acquired BMF syndromes.  

For detailed information, please download our Granting Round Information Document.

*Please note – the Program Full Application document has been amended. The Project Details section word count has been increased to 3000.

Application Templates are available for download:

GIA EOI Application

GIA Full Application

Program EOI Application

Program Full Application

Fellowship Application  

Please direct any enquiries or questions to Dr Simonne Neil

(e) [email protected]

Related Articles

First Alex Gadomski PhD Scholarship recipient announced

Maddie Riewoldt's Vision and the Menzies Institute for Medical Research at the University of....

Read more

The Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry reaches over 550 patients!

February 2025 The Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry (AAR) was the very first research project funded by Maddie’s Vision in 2016. As the major funder of ...

Read more

Gunn Family Women in Haematology Fellowship

Maddie's Vision, the Snowdome Foundation and the Gunn Family are proud to announce our....

Read more

Australian Marrow Failure Biobank Preliminary Application

Maddie Riewoldt’s Vision is delighted to announce the Australian Marrow Failure Biobank (AMFB) Preliminary Application is now open.

Read more

Sign up to be the first to hear about our upcoming News & Events